✦ LIBER ✦

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems

✍ Scribed by Margaret L MacMillan; Daniel J Weisdorf; John E Wagner; Todd E DeFor; Linda J Burns; Norma K.C Ramsay; Stella M Davies; Bruce R Blazar

Book ID: 117816226
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 181 KB
Volume: 8
Category: Article
ISSN: 1083-8791
DOI: 10.1053/bbmt.2002.v8.pm12171485

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Limited benefit of pentostatin salvage t

Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host disease

✍ Alam, Naheed; Atenafu, Eshetu G.; Tse, Garwin; Viswabandya, Auro; Gupta, Vikas; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

340: Response to Steroids as Primary The

340: Response to Steroids as Primary Therapy for Acute Graft-Versus-Host Disease (GVHD) in 280 Hematopoietic Stem Cell Transplant (HSCT) Recipients: Comparison of Unrelated Donor (URD) Bone Marrow (BM) and Umbilical Cord Blood (UCB)

✍ M.L. MacMillan; J.E. Wagner; M. Arora; T.E. DeFor; B.R. Blazar; D.J. Weisdorf 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Alemtuzumab for Steroid Refractory Acute

Alemtuzumab for Steroid Refractory Acute Graft Versus Host Disease in Pediatric Patients: A Retrospective Review of 12 Patients Reveals a Response Rate of 83%

✍ P. Khandelwal; A.H. Filipovich; P. Mehta; S. Jodele; M.S. Grimley; K. Myers; M.B 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Clinical Factors Predicting the Response

Clinical Factors Predicting the Response of Acute Graft-versus-Host Disease to Corticosteroid Therapy: An Analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation

✍ Murata, Makoto; Nakasone, Hideki; Kanda, Junya; Nakane, Takahiko; Furukawa, Tats 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Comparative Outcomes of Donor Graft CD34

Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation

✍ Pasquini, M. C.; Devine, S.; Mendizabal, A.; Baden, L. R.; Wingard, J. R.; Lazar 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 162 KB

Expression of T cell activation antigen

Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation

✍ van Esser, J W J; Bolhuis, R L H; Cornelissen, J J; Gadisseur, A P A; Gratama, J 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 59 KB